Evogliptin tartrate

SKU: orb1709723

Description

Evogliptin tartrate is a selective, orally active DPP-4 inhibitor developed for diabetes research, with emerging studies indicating its potential in atherosclerosis models by targeting vascular inflammation. In vitro and in vivo research explores its anti-inflammatory and endothelial protective effects beyond glycemic control.

Research Area

Cell Biology, Pharmacology & Drug Discovery, Protein Biochemistry

Key Properties

• CAS Number: 1222102-51-3
• MW: 551.51
• Formula: C₂₃H₃₂F₃N₃O₉
• SMILES: O[C@H]([C@@H](O)C(O)=O)C(O)=O.CC(C)(C)OC[C@H]1N(CCNC1=O)C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F
• Target: Autophagy,DPP-4

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

135395528